An FDA advisory panel has voted 11-7 to recommend that the FDA ban certain nonprescription inhalers because they contain propellants that harm the ozone layer. Among the products that would be affected by a ban is Wyeth Consumer Healthcare's Primatene Mist.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.